Volume-effect and radiotherapy [II]. Part II: Volume-effect and normal tissue;Effet volume en radiothérapie [II]. Deuxième partie: Volume et tolérance des tissus sains

Cancer/Radiotherapie

Volumn 7, Issue 5, 2003, Pages 353-362

  Huchet, A ^a   Caudry, M ^a   Belkacemi Y ^b   Trouette, R ^a   Vendrely, V ^a   Causse, N ^a   Recaldini L ^a   Atlan, D ^c   Maire, J P ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b CENTRE OSCAR LAMBRET   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Cancer; Mathematical models; Radiation therapy; Volume

Indexed keywords

CANCER CONTROL; CANCER RADIOTHERAPY; CORRELATION ANALYSIS; DOSE CALCULATION; DOSE RESPONSE; HUMAN; MATHEMATICAL MODEL; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

EID: 0142025241     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(03)00082-9     Document Type: Short Survey

References (71)

1. Abbatucci JS, Delozier T, Quint R, Roussel A, Brune D. Radiation myelopathy of the spinal cervical cord: time, dose and volume factors. Int J Radiat Oncol Biol Phys 1978;4:239-48.
2. Archambeau JO, Shymko RM. Tissue population configuration as a modifier of organ dose response. Int J Radiat Oncol Biol Phys 1988;15:727-34.
3. Armstrong CL, Hunter JV, Ledakis GE, Cohen B, Tallent EM, Goldstein BH, et al. Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology 2002;591:40-8.
4. Berg NO, Lindgren M. Relation between field size and tolerance of rabbit's brain to roentgen irradiation (200 kV) via a split-shaped field. Acta Radiol 1963;1:147-68.
5. Bijl HP, van Luijk P, Coppes RP, Schippers JM, Konings AW, van der Kogel AJ. Dose-volume effects in the rat cervical spinal cord after proton irradiation. Int J Radiat Oncol Biol Phys 2002;52:205-11.
6. Boden G. Radiation myelitis of the cervical spinal cord. Br J Radiol 1948;21:464-9.
7. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123-35.
8. Caudry M, Causse N, Trouette R, Récaldini L, Maire JM, Demaux H. Radiotoxic model for three-dimensional treatment planning. Part 1: Theoretical basis. Int J Radiat Oncol Biol Phys 1993;25:907-19.
9. Chin LM, Kijewski PK, Svensson GK, Chaffey JT, Levene MB, Bjarngard BE. A Computer-controlled radiation pelvic and para-aortic nodal areas. Int J Radiat Oncol Biol Phys 1981;7:61-70.
10. Cohen L. The statistical prognosis in radiation therapy. Am J Roentgenol 1960;84:741-53.
11. Cohen L. Derivation of cell population kinetic parameters from clinical statistical data (program RAD3). Int J Radiat Oncol Biol Phys 1978;4:835-40.
12. Cohen L. An iso-effect table for radiation tolerance of the human spinal cord. Int J Radiat Oncol Biol Phys 1981;7:961-6.
13. Cohen L. The tissue volume factor in radiation oncology. Int J Radiat Oncol Biol Phys 1982;8:1771-4.
14. Diallo I, Lamon A, Shamsasaldin A, Grimaud E, Vathaire F, Chavaudra J. Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 1996;38:269-71.
15. Dubray B, Pavy JJ, Giraud P, Danhier S, Cosset JM. Les tests prédictifs de la réponse à la radiothérapie : bilan et perspectives en 1997. Cancer Radiother 1997;1:473-83.
16. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
17. Followill D, Geis P, Boyer A. Estimate of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997;38:667-72.
18. Goffinet R, Marsa GW, Brown M. The effect of single and multifraction radiation courses on the mouse spinal cord. Radiology 1976;119:709-13.
19. Graham MV, Purdy JA, Emami B, Harms W, Bosh W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumontis after treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45:323-9.
20. Hendry J, Thames H. The tissue rescuing unit. Br J Radiol 1986;59:628-30.
21. Hopewell JW, Morris AD, Dixon-Brown A. The influence of field site on the late tolerance of the rat spinal cord to single doses of X-rays. Br J Radiol 1987;60:1099-108.
22. Hopewell JW, Trott KR. Volume effects in radiobiology as applied to radiotherapy. Radiother Oncol 2000;56:283-8.
23. Jaffray DA, Yan D, Young JW. Managing geometric uncertainty in conformal intensity-modulated radiation therapy. Semin Radiat Oncol 1999;9:4-19.
24. Jolles B. The reciprocal vicinity effect of irradiated tissues on a "diffusible substance" in irradiated tissues. Br J Radiol 1950;23:265.
25. Jones B, Dale RG. Mathematical models of tumor and normal tissue response. Acta Oncologica 1999;38:883-93.
26. Van der Kogel AJ. Radiation-induced damage in the central nervous system: an interpretation of target cell response. Br J Cancer 1986:207-17.
27. Van der Kogel AJ. Dose-volume effect in the spinal cord. Radiother and Oncol 1993;29:105-9.
28. Van der Kogel AJ. Radiobiological and clinical data on dose-volume effect relationship in normal tissues. Radiother Oncol 1993;29:127-8.
29. Kulik C, Mazurier J, Lartigau E. Probabilités de contrôle tumoral et de complications (TCP/NTCP) après radiothérapie : aspects méthod-ologiques, physique et biologiques. Cancer Radiother 2002;6(suppl 1):155s-65s.
30. Kutcher GJ, Burman C, Brewster MS. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 1989;16:1623-30.
31. Kutcher GJ, Burman C, Brewster MS, Goitein M, Mohan R. Histogram reduction method for calculating complication probability for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991;21:137-46.
32. Lartigau E, Dubray B, Mornex F. Mécanismes biologiques des effets tardifs des radiations ionisantes. Cancer Radiother 1997;1:669-76.
33. Lefkopoulos D, Viellevigne L, Grandjean P, Berre F, Dejean C. La planification inverse en radiothérapie d'intensité modulée. Cancer Radiother 1999;3:160-70.
34. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res 1985;104:S13-9.
35. Lyman JT, Wolbarst A. Optimization of radiation therapy, III: a method of assessing complication probability from dose-volumes histograms. Int J Radiat Oncol Biol Phys 1987;13:103-9.
36. Lyman JT. Normal tissue complication probabilities: variable dose per fraction. Int J Radiat Oncol Biol Phys 1992;22:247-50.
37. Maire JP, Coudin B, Demeaux H, Celerier D, Guerin J, Caudry M. Probable effect of cerebral irradiation on intellectual efficiency. Bull Cancer 1983;70:275-83.
38. Marcus R, Million RR. The incidence of myelitis after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys 1990;19:3-8.
39. Maynord WD. The mathematical theory of integral dose and its applications in practice. Br J Radiol 1944;17:359-67.
40. Michalowski AS, Weldon TE, Kirk J. Can cell survival parameters be deduced from non-clonogenic assays of radiation damage to normal tissues? Br J Cancer 1984;47:257-61.
41. Mornex F, Pavy JJ, Denekamp J, Bolla M. Scoring system of late effects radiations on normal tissues: the Soma-Lent scale. Cancer Radiother 1997;1:622-8.
42. Munro TR, Gilbert CW. The relation between tumor lethal dose and the radiosensivity of tumors cells. Br J Radiol 1961;34:246.
43. Niermierko A, Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother Oncol 1991;20:166-76.
44. Niermierko A. Dose-volume effect in the spinal cord. Radiother Oncol 1994;31:265-7.
45. Oldham M, Neal A, Webb S. A comparison of conventional "forward planning" With inverse planning for 3D conformal radiotherapy of the prostate. Radiother Oncol 1995;35:248-62.
46. Olsen DR, Kambestad BK, Kristoffersen DT. Calculation of radiation induced complication probabilities for brain, liver and kidney, and the use of a reliability model to estimate critical volume fractions. Br J Radiol 1994;67:1225-318.
47. Paterson R. Choice of technique time and dose. In: Paterson R, editor. The treatment of malignant diseases by radium and X-rays Being a practice of radiotherapy. London: Edward Arnold & Co.; 1953. p. 25.
48. Reinhold HS, Kaalen JG, Unger-Gils K. Radiation myelopathy of the thoracic spinal cord. Int J Radiat Oncol Biol Phys 1976;1:651-7.
49. Rosenwald JC, Papatheodorou S, Gaboriaud G, Ponvert D. La modulation d'intensité, pourquoi et comment ? Cancer Radiother 1999;3:150-9.
50. Rosenwald JC, Gaboriaud G, Ponvert D. La radiothérapie conformationnelle : principes et classification. Cancer Radiother 1999;3:367-77.
51. Rubin P, Casarett G. A direction for clinical radiation pathology. Frontiers of radiation therapy and oncology. Baltimore: Kargel, Basel and University Park Press; 1972. p. 1-16.
52. Rubin P, Constine LS, Fajardo LF, Philips TL, Wasserman TH, RTOG Late Effect Working Group. Overview of late effects normal tissues (Lent) scoring system. Int J Radiat Oncol Biol Phys 1992;22:569-71.
53. Schultheiss TE, Orton CG, Peck RA. Models in radiotherapy: volume effects. Med Phys 1983;10:410-5.
54. Schultheiss TE, Stephens LC, Ang KK, Price RE, Peters LJ. Volume effects in rhesus monkey spinal cord. Int J Radiat Oncol Biol Phys 1994;29:67-72.
55. Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. Int J Radiat Oncol Biol 1995;31:1093-112.
56. Shepherd S, Childs PJ, Graham JD, Warrington AP, Brada M. Whole body dose from linear accelerator-based stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1995;38:657-65.
57. Trott KR. Relation between cell survival and gross endpoints of tumor response and tissue failure. 2nd edition. In: Steel GG, Horwich A, Horwich A, editors. The biological basis of radiotherapy. New York: Elsevier Science Publisher B.V; 1989. p. 65-76.
58. Trouette R, Caudry M, Maire JP, Demaux H. Les dété riorations cérébrales postradiques de l'adulte : principal facteur limitant des irradiation encéphaliques ? Cancer Radiother 1993;80:209-21.
59. Tubiana M. Les effets cancérogènes des faibles doses de radiations. Cancer Radiother 1999;3:203-14.
60. Von Essen CF. Radiation tolerance of the skin. Acta Radiol Ther Phys Biol 1969;8:311-30.
61. Wigg DR, Koschel K, Hodgson GS. Tolerance of the mature human central nervous system to photon irradiation. Br J Radiol 1981;54:787-98.
62. Withers HR, McBride H. Biologic basis of radiation therapy. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott-Raven; 1997. p. 112.
63. Withers HR, Taylor JMG, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 1988;14:751-9.
64. Withers HR, Taylor JMG. Critical volume model. Int J Radiat Oncol Biol Phys 1992;25:151-2.
65. Wolbarst AB, Sternick ES, Curran BH, Dritschilo A. Optimized radiotherapy treatment planning using the complication probability factor (CPF). Int J Radiat Oncol Biol Phys 1980;6:723-8.
66. Wolbarst AB, Chin LM, Svensson GK. Optimization of radiation therapy: integral-response of a model biological system. Int J Radiat Oncol Biol Phys 1982;8:1761-9.
67. Wolbarst AB. Optimization of radiation therapy II: the critical-voxel model. Int J Radiat Oncol Biol Phys 1984;10:741-5.
68. Yaes RJ, Kalend A. Local stem cell depletion model for radiation myelitis. Int J Radiat Oncol Biol Phys 1988;14:1247-59.
69. Yaes RJ. The biological effect of inhomogeneous dose distribution in fractionated radiotherapy. Int J Radiat Oncol Biol Phys 1990;19:203-7.
70. Zaider M, Minerbo GN. Tumor control probability: a formulation applicable to any temporal protocol of dose delivery. Phys Med Biol 2000;45:279-93.
71. Zhou H, Suzuki M, Geard CR, Hei TK. Effects of irradiated medium with or without cells on bystander cell responses. Mutat Res 2002; 499:135-41.